About
Professor David Price is Founder and Head of The Observational and Pragmatic Research Institute (Singapore), a research-driven organisation that delivers pragmatic clinical trials and real-life database research across multiple geographies. He is an associate investigator on the CRE-PF on behalf of OPCA.
He is also Head of Optimum Patient Care (Global, Australia and UK), a social enterprise which focuses on disease registries and quality improvement in primary and secondary care led by internationally recognised experts in all areas of respiratory medicine. Major global initiatives include: The International Severe Asthma Registry (ISAR) with over 30 countries collaborating; collaboration On Quality Improvement Initiative for Achieving Excellence in Standards for COPD Care (CONQUEST) and quality improvement initiatives in Australia and the United Kingdom including asthma, COPD and rare disease audit programs in primary and specialist care.
David has completed previous research into the identification of early signs and symptoms of Interstitial Lung Disease (ILD).